PHARMEXA A/S

AUTOVAC

In the statement, Column 2, line 12 after the word vivo PRECLINICAL TESTING OF POTENTIAL DRUGS; IN VITRO AND IN VIVO should be inserted.;PHARMACEUTICAL PREPARATIONS FOR USE IN THE TREATMENT OF NEOPLASTIC DISORDERS, INFLAMMATORY DISORDERS, INFECTIOUS DISEASES, TRAUMATIC DISORDERS, METABOLIC DISORDERS, HEMATOLOGIC RESPIRATORY DISORDERS, VASCULAR AND CARDIAL DISORDERS, ENDOCRINOLOGIC DISORDERS, MUSCULAR DISORDERS, SKELETAL AND BONE DISORDERS, NEUROLOGICAL DISORDERS, SKIN AND MUCOSAL DISORDERS, PSYCHIATRIC DISORDERS, LYMPHATIC DISORDERS, INTESTINAL DISORDERS, UROLOGIC DISORDERS, AND REPRODUCTIVE DISORDERS; MEDICAL DIAGNOSTIC REAGENTS; DIAGNOSTIC PREPARATIONS FOR CLINICAL OR MEDICAL LABORATORY USE; VACCINES, INCLUDING THERAPEUTIC VACCINES, SUBCOMPONENT VACCINES, POLYPEPTIDE VACCINES, LIVE VACCINES, VIRAL VACCINES, NUCLEID ACID VACCINES AND DNA-VACCINES, VACCINE RECIPIENTS, VACCINE CARRIERS, VACCINES ADJUVANTS; NON-PATHOGENIC MICROORGANISMS AND VIRA FOR VACCINE USE, POLYPEPTIDES, PROTEIN AND NUCLEIC ACIDS, INCLUDING DNA FOR VACCINE USE;AUTO VAC;REAGENTS FOR SCIENTIFIC OR MEDICAL RESEARCH USE; DIAGNOSTIC PREPARATIONS FOR SCIENTIFIC OR RESEARCH USE;LIVE ANIMALS;SCIENTIFIC, INDUSTRIAL BIOTECHNOLOGICAL AND BIOMEDICAL RESEARCH; DEVELOPMENT OF THERAPEUTIC VACCINES, OTHER VACCINES AND PHARMACEUTICALS FOR OTHERS; CHEMICAL, BIOCHEMICAL AND MOLECULAR BIOLOGICAL ANALYSES; MEDICAL RESEARCH IN THE NATURE OF IN VITRO AND IN VIVO * PRECLINICAL TESTING OF POTENTIAL DRUGS; IN VITRO AND IN VIVO * RESEARCH CONCERNING THERAPEUTIC VACCINES, OTHER VACCINES AND POTENTIAL DRUGS; MEDICAL, CHEMICAL, SCIENTIFIC, BIOTECHNOLOGICAL, BIOMEDICAL AND MOLECULAR BIOLOGICAL CONSULTATION SERVICES PROVIDED IN CONNECTION WITH THE AFOREMENTIONED SERVICES; MEDICAL INDUSTRIAL, CHEMICAL, SCIENTIFIC, BIOTECHNOLOGICAL, BIOMEDICAL AND MOLECULAR BIOLOGICAL TESTING AND RESEARCH;

INOXELL

Pharmaceutical preparations and substances for the treatment of neoplastic disorders, inflammatory disorders; infectious diseases, traumatic disorders, metabolic disorders, hematologic respiratory disorders, vascular and cardial disorders, endocrinologic disorders, muscular disorders, skeletal and bone disorders, neurological disorders, skin and mucosal disorders, psychiatric disorders, lymphatic disorders, intestinal disorders, urologic disorders, and reproductive disorders; chemical preparations, namely, biochemical preparations for laboratory analyses, for diagnostic and therapeutic use and for in vivo analyses in medical science research; biochemicals, namely, proteins, polypeptides, peptides and nucleic acids, all of the aforesaid goods for medical, diagnostic, therapeutic or veterinary purposes; molecular biological vectors, including retrovirus, adenovirus, and vaccinia virus vectors, all of the aforesaid goods for medical, diagnostic, therapeutic or veterinary purposes; biological and biochemical libraries, used as medical, diagnostic, therapeutic or veterinary reagents, including DNA and peptide libraries, the aforesaid goods for medical, diagnostic, therapeutic and veterinary use; recombinant cell lines, including packaging cells for use in preparation of retrovirus used as reagents for medical and veterinary purposes;Chemical products, including biochemical products, namely, proteins, peptides, polypeptides, nucleic acids, and molecular biological vectors for scientific, diagnostic, therapeutic and research laboratory use; chemical preparations, namely, biochemical preparations for laboratory analyses, for diagnostic and therapeutic use and for in vivo analyses in life science research; biochemicals and biomedicals, namely, proteins, polypeptides, peptides, nucleic acids, molecular biological vectors, including retrovirus, adenovirus and vaccinia virus vectors all for scientific, research laboratory, diagnostic and therapeutic use; biological and biochemical libraries used as scientific, therapeutic, diagnostic and research laboratory reagents, including DNA and peptide libraries; recombinant cell lines, including packaging cells for use in preparation of retrovirus used as reagents for scientific and research purposes; chemical products for use in the development of pharmaceuticals, drug targets, and drug leads for medical science;Scientific, industrial, biotechnological and biomedical research; development and identification of pharmaceutical preparations drug leads; chemical, biochemical and molecular biological analyses; medical and scientific research, namely, in vivo and in vitro preclinical testing of drug leads; scientific, industrial biotechnological and biomedical consultancy concerning the above analyses, tests and research; biomedical and pharmaceutical clinical testing and research;

PHARMACCINES FOR LIFE

Pharmaceutical preparations and substances for the treatment of neoplastic disorders, inflammatory disorders, infectious diseases, traumatic disorders, metabolic disorders, hematologic respiratory disorders, vascular and cardial disorders, endocrinologic disorders, muscular disorders, skeletal and bone disorders, neurological disorders, skin and mucosal disorders, psychiatric disorders, lymphatic disorders, intestinal disorders, urologic disorders, and reproductive disorders; vaccines, namely, therapeutic vaccines, subcomponent vaccines, polypeptide vaccines, live vaccines, viral vaccines, nucleic acid vaccines and DNA vaccines, vaccine excipients, vaccine carriers, vaccines adjuvants; vaccines containing non-pathogenic microorganisms and vira; vaccines containing polypeptides, protein and nucleic acids, including DNA; 00;Chemical products for use in the development of pharmaceuticals, vaccines, namely therapeutic, subcomponent, polypeptide and live vaccines, viral and nucleic acids vaccines, DNA vaccines, vaccine excipients, vaccine carriers, and vaccine adjuvants for medical science; chemical preparations for analyses in laboratories for in vivo analyses for medical purposes; non-pathogenic microorganisms and vira for vaccine use, polypeptides, protein and nucleic acids, including DNA for vaccine use;PHARMACCINES;Scientific, industrial biotechnological and biomedical research; pharmaceutical, biomedical and biotechnological development of therapeutic vaccines, other vaccines and pharmaceuticals; chemical, biochemical and molecular biological analyses; medical and scientific research, namely in vitro and in vivo preclinical tests of potential drugs; medical and scientific research, namely in vitro and in vivo research concerning therapeutic vaccines, other vaccines and potential drugs; scientific, industrial biotechnological and biomedical consultancy concerning the above analyses, tests and research; biomedical and pharmaceutical clinical testing and research;

PHARMEXA

Pharmaceutical preparations and substances for the treatment of neoplastic disorders, inflammatory disorders, infectious diseases, traumatic disorders, metabolic disorders, hematologic respiratory disorders, vascular and cardial disorders, endocrinologic disorders, muscular disorders, skeletal and bone disorders, neurological disorders, skin and mucosal disorders, psychiatric disorders, lymphatic disorders, intestinal disorders, urologic disorders, and reproductive disorders; vaccines, namely, therapeutic vaccines, subcomponent vaccines, polypeptide vaccines, live vaccines, viral vaccines, nucleic acid vaccines and DNA vaccines, vaccine recipients, vaccine carriers, vaccines adjuvants; vaccines containing non-pathogenic microorganisms and vira; vaccines containing polypeptides, protein and nucleic acids, including DNA;Chemical products for use in the development of pharmaceuticals, vaccines, namely, therapeutic, subcomponent, polypeptide and live vaccines, viral and nucleic acids vaccines, DNA vaccines, vaccine excipients, vaccine carriers, and vaccine adjuvants for medical science; chemical preparations for analyses in laboratories for in vivo analyses for medical purposes; non-pathogenic microorganisms and vira for vaccine use, polypeptides, protein and nucleic acids, including DNA for vaccine use;Scientific, industrial biotechnological and biomedical research; pharmaceutical, biomedical and biotecnological development of therapeutic vaccines, other vaccines and pharmaceuticals; chemical, biochemical and molecular biological analyses; medical and scientific research, namely, in vitro and in vivo preclinical tests of potential drugs; medical and scientific research, namely, in vitro and in vivo research concerning therapeutic vaccines, other vaccines and potential drugs; scientific, industrial biotechnological and biomedical consultancy concerning the above analyses, tests and research; biomedical and pharmaceutical clinical testing and research;